We measured proliferation of a panel of breast cancer cells representing different subtypes (ER+PR+, HER2+, ER-HER2-, ER+HER2+) in response to PBS or 5μg/mL EPS in a time-dependent manner. Here, ERBB2 is linked to breast carcinoma.